Latest / Lafayette Louisiana News Today | 2 Min News | The Daily News Now!
Breakthrough Pill Extends Pancreatic Cancer Survival | Lafayette Louisiana News
FDA just approved Rasonque, a daily pill that could double survival for advanced pancreatic cancer patients—offering hope where there was little before. Targeting the elusive RAS proteins, it slashes death risk by 60% and extends median survival to 13 months, more than double chemo’s six. Already given to over 2,000 patients, it’s a game-changer for one of medicine’s toughest cancers—even if side effects like rash and nausea come with the breakthrough. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.